Concept Medical - Ability to Treat Diabetic Patients: With a Novel Combined DES and DCB in a Single Platform

 


Please continue watching the satellites programs presented at TCT 2019:

Transforming DCB Strategy

 

Future and Scope

 


CHAIRPERSONS
 

Concept Medical - Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform Antonio Colombo, MD 
Columbus Hospital/Maria 
Cecilia Hospital 
Milan, Italy 
Concept - Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform

Roxana Mehran, MD, FACC 
Mount Sinai School of Medicine
New York, NY

Concept - Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform Marie-Claude Morice, MD
Institut Cardiovasculaire
Paris Sud
Paris, France



FACULTY

Luca Testa, MD, PhD 
IRCCS Pol. S. Donato
Milan, Italy 


 

Sameer I. Dani, MD, DM 
Apollo CVHF Hospital
International Ltd
Ahmedabad, India


 
Paolo Vicinelli, MD 
ASST Ovest Milanese 
Travaco Siccomario, Italy


 
Prathap Kumar, MD 
Meditrina Hospital 
Kerala, India


 
Azeem Latib, MB, BCh
Montefiore Medical
Center / Albert Einstein
College of Medicine
New York, NY
Alfonso Ielasi, MD, FESC
S. Ambrogio Clinical Institute
Milan, Italy


 

 




AGENDA
 

Why do we need a dedicated DES for diabetes? Introducing the Abluminus concept
Roxana Mehran

Multicenter real world data from global registries
Luca Testa

Case 1: Step-by-Step treatment strategy of complex diabetic patient with Abluminus DES
Sameer Dani

Case 2: Abluminus in CHIP cases and outcomes
Paolo Vicinelli

Case 3: Diabetic patient – Multivessel disease with LM - 2 years IVUS follow-up
Prathap Kumar

The ABILITY DIABETES GLOBAL Imaging Study (randomised control trial comparing Abluminus DES vs. Xience)
Azeem Latib

The ABILITY DIABETES GLOBAL Trial: The largest randomised control trial with coronary stents for the diabetic population
Antonio Colombo

Panel Discussion and audience interaction
Discussants: Alfonso Ielasi, Paolo Vicinelli

 


 

 

Concept Medical - Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform

 

 This program was supported by: 

 

Concept Medical - Ability to Treat Diabetic Patients: With a Novel Combined DES and DCB in a Single Platform

Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform Ability to Treat Diabetic Patients: With a Novel Combined DES + DCB in a Single Platform